What is PCMC?

The Preclinical Cancer Models Consortium is dedicated to advancing best practices in preclinical cancer research by fostering collaboration among core directors and experts. Our mission is to optimize and standardize strategies related to in vivo cancer modeling and non-animal oncology models through shared expertise, innovative methodologies, and resource integration. By networking across institutions, we aim to enhance the reproducibility, efficiency, and translational impact of preclinical studies, ultimately accelerating the development of effective cancer therapies.